Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor T cell immunotherapy recipients.

ABSTRACT:

SUBMITTER: Sesques P 

PROVIDER: S-EPMC8786606 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature